ADARx Pharmaceuticals, Inc. Common Stock (ADRX) — Net Asset Momentum
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) recorded a net asset momentum of -47.5% as of December 2025, with net assets of $-202.25 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ADARx Pharmaceuticals, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
ADARx Pharmaceuticals, Inc. Common Stock Net Asset Momentum (2024–2025)
This chart tracks ADARx Pharmaceuticals, Inc. Common Stock's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is -47.5%, with net assets of $-202.25 Million USD as of December 2025.
Annual Net Asset History for ADARx Pharmaceuticals, Inc. Common Stock (2024–2025)
The table below shows the complete annual net asset history for ADARx Pharmaceuticals, Inc. Common Stock from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ADARx Pharmaceuticals, Inc. Common Stock stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-202.25 Million | $507.65 Million | $709.91 Million | ▼ -47.5% |
| 2024 | $-137.15 Million | $233.45 Million | $370.60 Million | — |